RRC ID 74468
著者 Shirayanagi T, Kazaoka A, Watanabe K, Qu L, Sakamoto N, Hoshino T, Ito K, Aoki S.
タイトル Weak complex formation of adverse drug reaction-associated HLAB57, B58, and B15 molecules.
ジャーナル Toxicol In Vitro
Abstract The combination of certain human leukocyte antigen (HLA) polymorphisms with administration of certain drugs shows a strong correlation with developing drug hypersensitivity. Examples of typical combinations are HLA-B*57:01 with abacavir and HLA-B*15:02 with carbamazepine. However, despite belonging to the same serotype, HLA-B*57:03 and HLA-B*15:01 are not associated with drug hypersensitivity. Recent studies have shown that several HLA polymorphisms are associated with multiple drugs rather than a single drug, all resulting in drug hypersensitivity. In this study, we compared the molecular structures and intracellular localization of HLA-B*57:01, HLA-B*58:01, and HLA-B*15:02, which pose risks for developing drug hypersensitivity, as well as HLA-B*57:03 and HLA-B*15:01 that do not present such risks. We found that HLA molecules posing risks have a low affinity for the subunit β2-microglobulin; notably, the weak hydrogen bond formed via Gln96 of the HLA molecule contributes to this behavior. We also clarified that these HLA molecules are easily accumulated in the endoplasmic reticulum, exhibiting a low expression on the cell surface. Considering that these hypersensitivity risk-associated HLA molecules form complexes with β2-microglobulin and peptides in the endoplasmic reticulum, we assumed that their low complex formation ability in the endoplasmic reticulum facilitates the interaction with multiple drugs.
巻・号 82
ページ 105383
公開日 2022-8-1
DOI 10.1016/j.tiv.2022.105383
PII S0887-2333(22)00080-7
PMID 35568130
MeSH Carbamazepine / toxicity Drug Hypersensitivity* / genetics Drug-Related Side Effects and Adverse Reactions* HLA Antigens / genetics HLA-B Antigens / chemistry HLA-B Antigens / metabolism Humans
IF 2.959
リソース情報
ヒト・動物細胞 HeLa